{"nctId":"NCT00707759","briefTitle":"Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection","startDateStruct":{"date":"2008-06"},"conditions":["Kidney Diseases"],"count":28,"armGroups":[{"label":"A: withdrawal steroids","type":"EXPERIMENTAL","interventionNames":["Drug: Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + Withdrawal Prednisone"]},{"label":"B","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + prednisolone"]}],"interventions":[{"name":"Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + Withdrawal Prednisone","otherNames":[]},{"name":"Tacrolimus (TAC)+ Mycophenolate Mofetil (MMF) + prednisolone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\< 16.0 years\n* Bone age of boys \\< 15 years, of girls \\< 13 years\n* Prepuberal Tanner Status I\n* First or second kidney transplant, living or deceased kidney donation\n* Immunosuppression with Tacrolimus (TAC),Mycophenolate mofetil (MMF)\n* Patients and parents, respectively, have given their written consent after enlightenment (informed consent)\n\nExclusion Criteria:\n\n* Irreversible rejection of former transplant\n* Highly reactive (\\> 30%) lymphocytotoxic antibodies within 12 months prior to transplantation\n* Suspected insufficient medication compliance in dialysis\n* Patients receiving a basic immunosuppression other than that prescribed in this protocol\n* Simultaneous therapy with growth hormone after renal transplant","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","maximumAge":"16 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Stimulation of Growth After 12 Months (Delta Z-score)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":"0.2"},{"groupId":"OG001","value":"0.6","spread":"0.1"}]}]}]},{"type":"SECONDARY","title":"Growth-factors (IGF-I, IGFBP-3) Bone Metabolism (FA, Ca/Cru, CaxP, 25(OH)VitD, FGF23, Klotho, PTH, DXA, pQCT) Insulin-sensitivity by ISI Method. Molecular Markers - Acute Rejection (FOXP3/IL-17). Acute Rejection Incidence/Protocol Renal Biopsy","description":null,"paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":12},"commonTop":[]}}}